I agree… just that it looks like DCB is trying to take credit for where we are today and the positive changes in the last 6 months, i.e., since he joined. He or the BOD cannot take away what Bisantrene as a drug is capable of way, the past trials which provides the opportunity for cancer cure for patients worldwide and financial rewards for SH. Last but not the least the efforts, the acumen which you and others before DCB brought to the table and identified large opportunities for cardio protection or FTO cannot be taken away by DCB. He can take credit for achievements/ changes since his arrival like COH agreement or certain appointments. Looking forward to the strategic update to see what else he has accomplished and what’s on the horizon.
AIMO.
I agree… just that it looks like DCB is trying to take credit...
-
- There are more pages in this discussion • 2,421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |